David Bullen, chief executive of the UK-listed feed additive manufacturer Anpario, is to relinquish his position and directorship and leave the company from the end of July.
Mr Bullen first joined the Kiotechagil business from Novartis in 2007, and oversaw the integration of Optivite and Meriden Animal Health to form the present Anpario Group. The company says he has now decided to pursue new opportunities and interests.
Richard Edwards, currently Anpario’s executive vice chairman will succeed Mr Bullen as chief executive. He joined Kiotech in 2006 as chief executive, and was responsible for the reverse takeover of Agil the following year and the subsequent acquisitions and sales. He also set up the group’s US subsidiary.
“Anpario’s board would like to thank David for his significant contribution in leading the successful development of the company in its transition to a robust, higher added-value and efficient business, and wishes him all success with his future endeavours,” says chairman Richard Rose.
“We are delighted that Richard Edwards has agreed to become chief executive to continue the development of the company in supplying global food producers with natural nutritional and biosecurity products that maximise animal performance and reduce disease risk.”